Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Jul 23, 2009

Premium

GE Healthcare this week launched the Mag Sepharose magnetic beads for the capture and selective enrichment of proteins and peptides.

According to the company, the visible, dense magnetic beads are easy to use, have simple flexible protocols and elution conditions optimized for both electrophoresis and mass-spec analysis.

The beads are available in a TiO2 Mag Sepharose format for enriching phosphopeptides from complex samples; protein A and protein G Mag Sepharose format for the capture of target proteins by immunoprecipitation; and NHS Mag Sepharose format for covalent coupling of any protein containing amine groups for pull-down experiments.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.